Shattuck Labs, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a STTK research report →
Companywww.shattucklabs.com
Shattuck Labs, Inc. , a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers.
- CEO
- Taylor H. Schreiber
- IPO
- 2020
- Employees
- 44
- HQ
- Austin, TX, US
Price Chart
Valuation
- Market Cap
- $295.56M
- P/E
- -13.88
- P/S
- 295.56
- P/B
- 7.23
- EV/EBITDA
- -4.34
- Div Yield
- 0.00%
Profitability
- Gross Margin
- -82.00%
- Op Margin
- -5266.40%
- Net Margin
- -4987.40%
- ROE
- -60.73%
- ROIC
- -53.81%
Growth & Income
- Revenue
- $1.00M · -82.52%
- Net Income
- $-48,809,000 · 35.28%
- EPS
- $-0.70 · 53.02%
- Op Income
- $-51,508,000
- FCF YoY
- 34.04%
Performance & Tape
- 52W High
- $8.33
- 52W Low
- $0.71
- 50D MA
- $6.69
- 200D MA
- $3.69
- Beta
- 1.19
- Avg Volume
- 649.17K
Get TickerSpark's AI analysis on STTK
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Stout Stephen | other | 12,805 |
| May 15, 26 | Stout Stephen | other | 12,805 |
| May 12, 26 | Neill Andrew R | other | 64,027 |
| May 12, 26 | Neill Andrew R | other | 64,027 |
| May 12, 26 | Shukla Abhinav A. | other | 2,032 |
| May 12, 26 | Shukla Abhinav A. | sell | 2,032 |
| May 12, 26 | Shukla Abhinav A. | other | 2,032 |
| May 12, 26 | Pandite Arundathy N. | sell | 30,000 |
| May 12, 26 | Schreiber Taylor | other | 25,610 |
| May 12, 26 | Schreiber Taylor | other | 25,610 |
Our STTK Coverage
We haven't published any research on STTK yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate STTK Report →